Technical Analysis for CYTK - Cytokinetics, Incorporated

Grade Last Price % Change Price Change
grade A 10.47 0.58% 0.06
CYTK closed up 0.58 percent on Monday, May 20, 2019, on 78 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical CYTK trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Slingshot Bullish Bullish Swing Setup 0.58%
NR7 Range Contraction 0.58%
Upper Bollinger Band Walk Strength 0.58%
Wide Bands Range Expansion 0.58%
Overbought Stochastic Strength 0.58%
Shooting Star Candlestick Bearish -2.42%

Older signals for CYTK ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Cytokinetics, Incorporated, a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. Its lead drug candidate from its cardiac muscle contractility program, omecamtiv mecarbil, is in Phase II clinical development for the potential treatment of heart failure. The company also holds an exclusive license worldwide to develop and commercialize omecamtiv mecarbil and related compounds, subject to Cytokinetics' specified development and commercialization participation rights. Cytokinetics is independently developing Tirasemtiv and CK-2127107, which are skeletal muscle activators, as potential treatments for diseases and medical conditions associated with aging, muscle wasting, or neuromuscular dysfunction. Tirasemtiv is in Phase II clinical trials program and has been granted orphan drug designation and fast track status by the U.S. Food and Drug Administration and orphan medicinal product designation by the European Medicines Agency for the potential treatment of amyotrophic lateral sclerosis, a debilitating disease of neuromuscular impairment, in which treatment with tirasemtiv produced potentially clinically relevant pharmacodynamic effects in Phase II trials. The company has a strategic alliance with Amgen Inc. to discover, develop, and commercialize small molecule therapeutics that activate cardiac muscle contractility for applications in the treatment of heart failure. Cytokinetics, Incorporated was founded in 1997 and is headquartered in South San Francisco, California.
Biopharmaceutical Diseases Disease Neuroscience Serious Diseases Anatomy Heart Failure Amyotrophic Lateral Sclerosis Nervous System Astellas Pharma Treatment Of Heart Failure Treatment Of Serious Diseases
Is CYTK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 11.33
52 Week Low 5.75
Average Volume 617,485
200-Day Moving Average 7.7205
50-Day Moving Average 8.768
20-Day Moving Average 9.505
10-Day Moving Average 10.01
Average True Range 0.6248
ADX 31.98
+DI 33.615
-DI 14.1898
Chandelier Exit (Long, 3 ATRs ) 9.4556
Chandelier Exit (Short, 3 ATRs ) 9.6344
Upper Bollinger Band 10.9702
Lower Bollinger Band 8.0398
Percent B (%b) 0.83
BandWidth 30.830089
MACD Line 0.5485
MACD Signal Line 0.4325
MACD Histogram 0.116
Fundamentals Value
Market Cap 561.88 Million
Num Shares 53.7 Million
EPS -0.34
Price-to-Earnings (P/E) Ratio -30.79
Price-to-Sales 6.91
Price-to-Book 3.91
PEG Ratio -0.34
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.09
Resistance 3 (R3) 11.07 10.85 10.98
Resistance 2 (R2) 10.85 10.69 10.86 10.95
Resistance 1 (R1) 10.66 10.60 10.76 10.68 10.91
Pivot Point 10.44 10.44 10.49 10.45 10.44
Support 1 (S1) 10.25 10.28 10.35 10.27 10.03
Support 2 (S2) 10.03 10.19 10.04 9.99
Support 3 (S3) 9.84 10.03 9.96
Support 4 (S4) 9.86